期刊
TRENDS IN ENDOCRINOLOGY AND METABOLISM
卷 20, 期 6, 页码 295-302出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2009.03.005
关键词
-
资金
- NINDS NIH HHS [R01 NS033335-15, R01 NS033335] Funding Source: Medline
Large epidemiologic studies have established that diabetes, hyperlipidemia and obesity all increase the risk for cardiovascular disease. However, the precise mechanisms by which these metabolic disorders increase the propensity to develop atherosclerosis are not known. Recently, the concept of the metabolic syndrome - a constellation of conditions including obesity, hypertension, hyperlipidemia and insulin resistance - has received much attention. Studies on the metabolic syndrome might enable a better understanding of the underlying biological mechanisms that lead to cardiovascular disease. This review focuses on endothelial nitric oxide synthase and summarizes evidence that a reduction in the bioavailability of endothelium-derived nitric oxide serves as a key link between metabolic disorders and cardiovascular risk.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据